Cargando…
Health and economic benefits of public financing of epilepsy treatment in India: An agent‐based simulation model
OBJECTIVE: An estimated 6–10 million people in India live with active epilepsy, and less than half are treated. We analyze the health and economic benefits of three scenarios of publicly financed national epilepsy programs that provide: (1) first‐line antiepilepsy drugs (AEDs), (2) first‐ and second...
Autores principales: | Megiddo, Itamar, Colson, Abigail, Chisholm, Dan, Dua, Tarun, Nandi, Arindam, Laxminarayan, Ramanan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019268/ https://www.ncbi.nlm.nih.gov/pubmed/26765291 http://dx.doi.org/10.1111/epi.13294 |
Ejemplares similares
-
Potential impact of introducing the pneumococcal conjugate vaccine into national immunisation programmes: an economic-epidemiological analysis using data from India
por: Megiddo, Itamar, et al.
Publicado: (2018) -
The need for better evidence to evaluate the health & economic benefits of India's Rashtriya Swasthya Bima Yojana
por: Nandi, Arindam, et al.
Publicado: (2015) -
Public finance of universal routine childhood immunization in India: district-level cost estimates
por: Schueller, Emily, et al.
Publicado: (2021) -
The Socioeconomic and Institutional Determinants of Participation in India’s Health Insurance Scheme for the Poor
por: Nandi, Arindam, et al.
Publicado: (2013) -
Breastfeeding Duration and Adolescent Educational Outcomes: Longitudinal Evidence From India
por: Nandi, Arindam, et al.
Publicado: (2017)